Essbrains Pharma Private Limited, a active private limited company, was established on 06 September 2013 in Kunnathunad, Kerala, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24233KL2013PTC034952. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Saji Jose (Managing Director), Sreejith Sreekumar (Director), Pramod Parameswaran (Director). Past directors included Stanly Joseph, Sreejith Sreekumar, Scaria Thombil George. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 69 Kinfra Small Industries Park, Nellad P O, Kunnathunad, Kerala, 686669.
U24233KL2013PTC034952
034952
06 September 2013
₹0.10 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Essbrains Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saji Jose | Managing Director | 06 Sep 2013 | Current |
| Sreejith Sreekumar | Director | 27 Dec 2021 | Current |
| Pramod Parameswaran | Director | 27 Dec 2021 | Current |
| Shanty Saji | Director | 01 Oct 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Essbrains Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.96% increase. The company also saw a substantial fall in profitability, with a 185.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 65.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Essbrains Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Essbrains Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Essbrains Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Essbrains Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Essbrains Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Essbrains Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
Progress on Sreejith Sreekumar was appointed as a Director was appointed as a Director on 27 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
Progress on Pramod Parameswaran was appointed as a Director was appointed as a Director on 27 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
Progress on Shanty Saji was appointed as a Director was appointed as a Director on 01 Oct 2015 & has been associated with this company since 10 years 2 months . was documented.
Saji Jose was appointed as a Managing Director was appointed as a Managing Director on 06 Sep 2013 & has been associated with this company since 12 years 2 months . was recorded as a recent event.
The CIN of Essbrains Pharma Private Limited is U24233KL2013PTC034952.
Essbrains Pharma Private Limited is headquartered at Plot No 69 Kinfra Small Industries Park, Nellad P O, Kunnathunad, Kerala, 686669.
Essbrains Pharma Private Limited was incorporated on 06 September 2013.
The current directors of Essbrains Pharma Private Limited are
The primary industry of Essbrains Pharma Private Limited is Manufacturing.
Essbrains Pharma Private Limited is unlisted.
The authorized capital of Essbrains Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Essbrains Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX